Monograph: Lecithin
Help on accessing alternative formats, such as Portable document format (PDF), Microsoft word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
Date:
2019-07-01
NHPID name
Lecithin ( USP 2008a )Proper name(s)
- 1,2-Diacylglycero-3-phosphocholine ( Unavailable )
- 1,2-diacyl-sn-glycero-3-phosphocholine ( Unavailable )
- Lecithin ( Unavailable )
Common name(s)
Lecithin ( Unavailable )Source material
- Salmo salar (Unavailable)
- Soya Oil (Unavailable)
Route Of administration
OralDosage form(s)
The acceptable pharmaceutical dosage forms suited to oral administration include, but are not limited to, chewables (e.g. gummies, tablets), caplets, capsules, strips, lozenges, powders or liquids where the dose is measured in drops, teaspoons or tablespoons. This labelling standard is not intended to include foods or food-like dosage forms such as bars, chewing gums or beverages.Use(s) or purpose(s)
Statement(s) to the effect of:
Helps to support liver function.Dose(s)
Adults:
Dose(s):
1 Day per day
Duration of use
No statement is requiredRisk information
Statement(s) to the effect of:
Caution(s) and Warning(s): No statement is required Contraindication(s): No statement is required Known Adverse Reaction(s): No statement is requiredNon-medicinal ingredients
Must be chosen from the current Natural health products ingredients database and must meet the limitations outlined in the database.Specifications
- The finished product specifications must be established in accordance with the requirements described in the NHPD Quality of natural health products guide.
- The medicinal ingredient must comply with the requirements outlined in the Natural health products ingredient database (NHPID).